Status:
COMPLETED
Sigmoid Colon Organ Motion in Radiotherapy
Lead Sponsor:
National Cheng-Kung University Hospital
Conditions:
Sigmoid Cancer
Sigmoid Colon Cancer
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Radiotherapy is used in cancer treatment to eradicate microscopic cancer cells to lower the risk of recurrence. The radiotherapy plan must account for organ movement inside the body to ascertain adequ...
Detailed Description
Day-to-day positioning variations contribute to uncertainty in radiotherapy. The International Commission on Radiation Units and Measurements (ICRU) report 62 recommended a margin added to the clinica...
Eligibility Criteria
Inclusion
- Patients with pathologically confirmed sigmoid colon cancer, who have received surgical excision (AR or LAR).
- Anastomosis of the colon must be performed with a surgical stapler, with the staple visible on CT imaging.
Exclusion
- Gross recurrent disease (defined as visible mass on CT imaging) in the pelvis.
- Other malignancy within the pelvic cavity.
- Previous surgery to the pelvic cavity other than AR/LAR.
- Pregnant or lactating females.
- Subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures.
Key Trial Info
Start Date :
December 6 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT03259828
Start Date
December 6 2017
End Date
December 31 2020
Last Update
February 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cheng Kung University Hospital
Tainan, Taiwan, 704